Categories
All News

April 26th Deadline in Lawsuit for Investors in MultiPlan Corporation (NYSE: MPLN) shares

Investors who purchased shares of MultiPlan Corporation (NYSE: MPLN) have certain options and there are strict and short deadlines running. Deadline: April 26, 2021. NYSE: MPLN) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

According to the complaint filed in the U.S. District Court for the Southern District of New York the plaintiff alleges on behalf of purchasers of MultiPlan Corporation (NYSE: MPLN) common shares between July 12, 2020 and November 10, 2020, that the defendants violated Federal Securities Laws.

More specifically, the plaintiff claims that between July 12, 2020 and November 10, 2020, the defendants made materially false and misleading statements in connection with the Merger and between July 12, 2020 and November 10, 2020 regarding the business, operation, and prospects of MultiPlan.

Those who purchased shares of MultiPlan Corporation (NYSE: MPLN) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.